With the completion of the two transactions announced, MedLife will have 41 acquisitions in its portfolio, being also the operator with the greatest expertise in such projects. According to company representatives, other transactions will follow until the end of 2022.
“The two acquisitions are a natural step in expanding our operations in the center of the country. We are already present in both towns (ed. Sfantu Gheorghe and Targu Mures) with outpatient and laboratory facilities. The new acquisitions will complement existing services, representing new facilities for both corporate clients and individual patients,” said Dorin Preda, Executive Director, MedLife Group.
With an activity of over 25 years on the market of private medical services in Romania, the Medical Center of Gastroenterology in Targu Mures is recognized locally for its excellent services in the field of digestive pathology. The unit has an efficient department for the diagnosis and modern treatment of digestive disorders with high risk of morbidity such as: esophagitis, ulcer disease, gastritis, liver cirrhosis, acute and chronic pancreatitis, but also a department dedicated to the diagnosis and treatment of liver disease and lesions.
Unlike the center in Targu Mures, the Medical Diagnostic and Imaging Center in Sfantu Gheorghe has more recently entered the private medical services market in Romania and is recognized for medical imaging services, being equipped with a high-performance CT scanner and a series of ultrasound scans for breast, abdominal, cardiovascular and other investigations. In addition to the imaging area, the Center also provides medical services for other specialties such as neurology, nephrology, orthopedics, cardiology and vascular surgery.
MedLife Group registered pro-forma consolidated turnover of RON1.632 million (EUR332 million) in 2021, 51.6% higher than in 2020, and a net profit of RON123 million, up 93% on the year, in line with its financial report published on the stock market.
In the first quarter of 2022, MedLife reported consolidated net profit of RON32 million for and a turnover of RON431 million.
Medlife SA, listed on the Bucharest Stock Exchange, has a stock market capitalization of RON2.6 billion. Its main shareholders are Mihai Marcu, with a 15.4% stake, Mihaela Cristescu, with 14%, Nicolae Marcu, with 10.5%, and pension fund Fondul de Pensii NN with 12.8%.